Skip to main content
. 2024 Jul 20;36:100517. doi: 10.1016/j.ensci.2024.100517

Table 1.

The HD survey (English translation) on the impact of COVID-19 pandemic on patients with Huntington's disease and their caregivers in the Auvergne-Rhone Alpes region.

Section I: General information
  • 1)

    Who is the person completing the survey?

(The patient - The caregiver - Both)
  • 2)

    How old are you?

    (Select the numbers of years)

  • 3)

    Are you a man or a woman?

    (Man – Woman)

  • 4)

    Where do you live?

    (At home alone – At home with family- Institution)

Section II: Medical information about HD and COVID-19 disease
  • 1)

    Do you have any HD symptoms?

    (Yes – No)

  • 2)

    How many years have you had HD symptoms?

    (Select the numbers of years)

  • 3)

    Do you need help in daily life activities?

    (No help – Help for some activities – Completely dependent)

  • 4)

    Did you have a diagnosis of COVID-19?

    (Yes – No)

    If Yes, how was the diagnosis confirmed?

    (Swab – Serological test - Both)

    If Yes, have you been hospitalized?

    (Yes – No)

    If Yes, how did the COVID-19 change your HD symptoms?

    (No change – Worsening of symptoms – New symptoms onset)

    If Yes, did you experience a social isolation?

    (Yes – No)

  • 5)

    Did the global health crisis due to the first wave of COVID-19 modify your HD symptoms during the three following months?

    (Yes, I had a worsening of my usual symptoms – Yes, I had new symptoms- No change)

    If Yes, I had a worsening of my usual symptoms: which ones?

    (Select the text, more than one answer is possible)

    If Yes, I had new symptoms: which ones?

    (Select the text, more than one answer is possible)

  • 6)

    Did you need to change your medical treatment during the first wave of pandemic and the three following months?

    (Yes, I needed to increase the daily dose and/or the frequency of one or more medications – Yes, I needed to add one or more new medications- No change)

Section III: The impact of COVID-19 on overall standard care of patients with HD and on their caregivers
  • 1)

    Did you experience any problem in the standard care of your HD during the first pandemic and the three following months?

    (Yes – No)

    If Yes, which are the problems identified?

(Select the text, more than one answer is possible)
  • 2)

    During the pandemic, was the standard neurological follow-up realized?

    Yes, by in-person visits- Yes, by phone calls- Yes, by virtual meetings- Not realized at all (more than one answer is possible).

  • 3)

    Did you need a psychological follow-up during and after the first pandemic?

    (Yes – No)

If Yes, how was it possible?
(By in-person visits- By phone calls- By virtual meetings- Not possible)
  • 4)

    Did you need to increase or start a psychological follow-up during and after the pandemic?

    (Yes – No)

    If Yes, was it possible?

    (Yes – No)

  • 5)

    Do you think that the difficulties in the management of your HD during and after the pandemic negatively impacted your caregiver(s) and/or your family?

    (Yes – No)

  • 6)

    Do you think that the overall management of your HD was appropriate during and after the pandemic?

    (Yes – No)

    If No, how do you think it could be improved in the future?

    (Select the text, more than one answer is possible)